Uniqure NV UQ1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 02/03/23 CET
20.23quote price arrow up+0.89 (+4.63%)
52 week range
18.80 - 21.24
Loading...
  • Open20.23
  • Day High20.23
  • Day Low20.23
  • Prev Close21.80
  • 52 Week High21.24
  • 52 Week High Date01/18/23
  • 52 Week Low18.80
  • 52 Week Low Date01/31/23

Key Stats

  • Market Cap1,053.96M
  • Shares Out46.82M
  • 10 Day Average Volume3.64
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-3.39

KEY STATS

  • Open20.23
  • Day High20.23
  • Day Low20.23
  • Prev Close21.80
  • 52 Week High21.24
  • 52 Week High Date01/18/23
  • 52 Week Low18.80
  • 52 Week Low Date01/31/23
  • Market Cap1,053.96M
  • Shares Out46.82M
  • 10 Day Average Volume3.64
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-3.39

RATIOS/PROFITABILITY

  • EPS (TTM)-2.74
  • P/E (TTM)-7.38
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Uniqure NV

 

Profile

MORE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing...
David Meek
Non-Executive Independent Chairman of the Board
Matthew Kapusta CPA
Chief Executive Officer, Executive Director
Pierre Caloz
Chief Operations Officer
Christian Klemt CPA
Chief Financial Officer
Alexander Kuta Ph.D.
Executive Vice President - Quality and Regulatory Affairs
Address
Paasheuvelweg 25a
Amsterdam
1105 BP
Netherlands